Limiting the Development of Anti-Cancer Drug Resistance in a Spatial Model of Micrometastases
Ami B Shah, Katarzyna A Rejniak, Jana L Gevertz
This study uses a spatial model to show that certain fractionated-dose chemotherapy protocols are as effective as metronomic therapy in reducing micrometastases with acquired or pre-existing resistance.
bioRxiv · Mar 4, 2016Systems Biology